A Phase 3b, Multicenter, Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia Who Have Previously Participated in a Trial of Titrated Oral SAMSCA (Tolvaptan)
Phase of Trial: Phase III
Latest Information Update: 05 Jul 2019
Price : $35 *
At a glance
- Drugs Tolvaptan (Primary)
- Indications Hyponatraemia
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 01 Jul 2019 This trial has been completed in UK - MHRA, according to European Clinical Trials Database.
- 08 Nov 2017 This study has been completed in Belgium as per European Clinical Trials Database.
- 27 Oct 2017 Status changed from active, no longer recruiting to discontinued.